ReleaseWire

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is pleased to announce the launch of its new line of gas chromatography (GC) capillary columns. These columns offer unparalleled performance and reliability, making them an essential tool for laboratories looking to achieve precise and accurate analytical results.

Harvard University educated archaeologist, current president of the applied archaeology firm, PRC, Inc., non-profit Ararat Conservation, Inc., and former maritime executive, Joel Klenck, reports, "It is 100% certain that a prehistoric site is Noah's Ark, located in the southern gorge of greater Mount Ararat and dating to an interval within the Late Epipaleolithic period (13,100-9,600 BC). This site exhibits all traits of an ancient Trot-on / Trot-off maritime barge, being unlike all terrestrial structures."

Global Markets Direct's, 'Chronic Bronchitis - Pipeline Review, H1 2014', provides an overview of the Chronic Bronchitis's therapeutic pipeline.

Global Markets Direct's, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2014', provides an overview of the Diffuse Large B-Cell Lymphoma's therapeutic pipeline.

Global Markets Direct's, 'Type 2 Diabetes - Pipeline Review, H1 2014', provides an overview of the Type 2 Diabetes's therapeutic pipeline.

Global Markets Direct's, 'Infinity Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Infinity Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

Global Markets Direct's, 'Imaxio - Product Pipeline Review - 2014', provides an overview of the Imaxio's pharmaceutical research and development focus.

Pramod Goel, CEO and founder of PlacidWay, an international medical resource and provider based in Denver, Colorado, is an expert in the medical tourism industry. His company has become one of the most popular, and leading, medical tourism providers in the country. Despite border fears, consumers from North America as well as Canadian provinces continue to flock south of the border for a variety of medical and dental care options.

Being pregnant is a momentous time in a woman’s life and preparing for a new baby is a daunting challenge for even the most organized mothers-to-be. Understanding this, Pascoe Chiropractic, a well-known chiropractic center offers the most effective pregnancy care through the holistic approach.

Body building can be hard work. Whether you are doing it to stay fit and healthy, to appear bigger, or for aesthetics sake, muscles can be tricky and take a long while to gain and only a very short time to lose. If you are planning on bulking up, the best way to do it is with the help of supplements and protein in order to put all your exercise into good use and bring muscle growth to its full potential.

Herpes is an annoying and contagious skin condition caused by herpes simplex virus. Herpes simplex virus is infectious and can be transmitted from one person to another. It can be very painful if left untreated. Author Melanie Addington designed a new downloadable book, Ultimate Herpes Protocol, which composes of many effective guides and treatments to treat this viral disease. The key factor of this product is that its long lasting in treating the herpes impressively by natural medicines.

Get Rid of Herpes consists of content which is designed to work for both men and women. This eBook is getting widely acclaimed and has created shock waves in the entire holistic community. To further mention, Sarah Wilcox has detailed a simple natural method to eliminate herpes from the body in Get Rid of Herpes and there is absolutely no talk about herbal supplements or topical ointments.

With the increasing popularity of the natural weight-loss supplement Cenaless, the editors of TesteDeEmagrecimento.com decided to finally review the fat blocker and perform personal tests to ensure that it actually gives the claimed results. Impressed by the performance of Cenaless, the website is now not only suggesting the supplement to its followers but is also offering a rare 20% discount.

On the back of more promising a macroeconomic outlook in 2014, we believe the Canadian pharmaceutical and healthcare market will be more attractive to pharmaceutical companies. Although drugmakers will continue to face generic competition and drug pricing pressure in the country, improving healthcare coverage and broader drug reimbursement lists will increase patients' access to medicines and provide revenue-generating opportunities for drugmakers.

Israel's pharmaceutical industry is well developed and export-driven. It is also a very attractive prospect for multinationals looking to launch innovative medicines due to a greater need for specialty treatments, thereby capitalising on the country's strong academic research infrastructure. Favourable factors include high per capita spending on medicines, a market size approaching US$2bn, a high proportion of pensioners and a largely urbanised population. However, we caution that poor patent respect and a lack of business transparency remain key threats to company revenues. Additionally, we hold a relatively less optimistic outlook for growth in the market, based on weaker private consumption over the medium term.

The market for eyewear in the Netherlands is very developed, marked by high penetration for spectacle frames and contact lenses. Manufacturers are trying to stimulate consumers to shift towards more advanced products in lenses, including corrective formulas and extensions that offer more comfort and hygiene. In spectacle frames manufacturers are trying to tackle maturity by stimulating consumers to use the products as a fashion statement. Consumers are encouraged to purchase spectacle frames...

Pharmaceutical firms in India are reporting improved performance for the quarter ended December 2013. This is an early indication of a recovery in the Indian pharmaceutical industry, following the implementation of the Drug Price Control Order in May 2013. While we forecast strong growth for the sector in 2014, persisting issues such as the halting of clinical trials, low healthcare expenditure and company-specific manufacturing quality control problems will continue to pose downside risks to our outlook.

New legislation encouraging generic drug use is an important step in bringing high quality medicines to the Chilean market and eventually improving access to medicines in the country. The tightened bioequivalent regulations will boost genuine medicine sales and force similares out of the market. However, we believe the current lack of vigilance in bioequivalence regulations in Chile has allowed the proliferation of low quality medicines in the market. Despite the ongoing capacity issues reported by domestic manufacturers, we believe local generic drugmakers need to adopt production processes that guarantee the quality of their drugs and improve their global competitiveness. We expect stronger political and legal intervention to address the monopoly issue in the country's pharmacy sector and improve drug access. The bulk purchasing of medicines by CENABAST will further reduce medicine prices in Chile's public health sector due to the increasing competitiveness of the international pharmaceutical markets.

Global Markets Direct's, 'Non-Hodgkin Lymphoma - Pipeline Review, H1 2014', provides an overview of the Non-Hodgkin Lymphoma's therapeutic pipeline.

Global Markets Direct's, 'Psoriasis - Pipeline Review, H1 2014', provides an overview of the Psoriasis's therapeutic pipeline.

Global Markets Direct's, 'Metastatic Liver Cancer - Pipeline Review, H1 2014', provides an overview of the Metastatic Liver Cancer's therapeutic pipeline.

Global Markets Direct's, 'Nasopharyngeal Cancer - Pipeline Review, H1 2014', provides an overview of the Nasopharyngeal Cancer's therapeutic pipeline.

Global Markets Direct's, 'Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2014', provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris)'s therapeutic pipeline.

GlobalData's clinical trial report, "Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014" provides data on the Gastroesophageal (GE) Junction Carcinomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroesophageal (GE) Junction Carcinomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastroesophageal (GE) Junction Carcinomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014" provides data on the Hormone-Sensitive Prostate Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hormone-Sensitive Prostate Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hormone-Sensitive Prostate Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Iroko Pharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Iroko Pharmaceuticals, LLC's pharmaceutical research and development focus.

Global Markets Direct's, 'Brain Metastasis - Pipeline Review, H1 2014', provides an overview of the Brain Metastasis's therapeutic pipeline.